Article

Financial Times on 2023-12-01 14:52

Pfizer Inc: Pfizer drops plan for twice-daily obesity pill due to side effects

Decision is setback for US drugmaker looking to increase sales after pandemic

Pfizer

Related news

FPfizer Inc: Pfizer to test once-daily weight loss pill ft.com
Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous Seattle Times
EU watchdog approves Pfizer COVID pill timesofmalta.com
Israel , Canada , United States , Europe
Antiviral Covid pill 89% effective, Pfizer says BBC
Bennett: Israel looking into Pfizer COVID pill israelnationalnews.com
Israel
Pfizer reporting strong demand for COVID pill israelnationalnews.com
Failed Alzheimer’s drug finds new life as anti-obesity pill newatlas.com
Phase 2
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial Forbes
Europe , Madrid , Phase 1 , Pill unter dem Bache
Merck says experimental pill cuts worst effects of COVID-19 Merced Sun-Star
Africa , Europe , Latin America
Merck says experimental pill cuts worst effects of covid-19 Arkansas Online
Africa , Europe , Latin America